The NPPA has sought greater say in formulating the list of essential medicines. At present, the NPPA is not involved in the preparation of the National List of Essential Medicines. Its role is to fix prices of these drugs once they are included in the Drug Price Control Order.
It has also asked the government not to take away its special powers to fix the ceiling prices of drugs when it lacks data or if there is a national emergency. The department proposes to allow the NPPA use this power only on its direction. The department used this provision to fix the price of coronary stents.
The government also plans to allow the NPPA to fix prices only of ‘off-patent’ medicines. ‘In-patent’ medicines will not be
subjected to price ceilings by the NPPA, according to the proposed draft. The draft suggests ‘overcharge’ be realised from the actual defaulting agency, manufacturers, distributors or retailers.
The government intends to amend the Drug Price Control Order so that the NPPA can monitor availability of drugs. It proposes
to allow the NPPA to take time to fix prices of drugs instead of binding it to a 60-day deadline.